Christine Spinka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christine Spinka has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Jordan M. Thomas
Division of Animal Sciences, University of Missouri, Columbia, MO 65211, USA
3 shared publications - Abu Saleh Mohammad Mosa
University of Missouri School of Medicine
2 shared publications - Carol Reynolds Geary
College of Medicine, University of Nebraska Medical Center
2 shared publications - Scott E. Poock
Department of Veterinary Medicine and Surgery, University of Missouri, Columbia 65211
2 shared publications - Adella B. Lonas
Department of Animal Science, University of Tennessee, Knoxville, TN 37996, USA
1 shared publication - Albert M. Lai
Institute for Informatics, Data Science, and Biostatistics, Washington University School of Medicine, St. Louis, MO, USA
1 shared publication
Latest Publications
- Open Access
Tandem Administration of Prostaglandin F2α and Gonadotropin-Releasing Hormone in Beef Heifers and Cows as a Convergent Presynchronization Method in the 7 & 7 Synch Protocol
An experiment was designed to evaluate modifications to the 7 & 7 Synch protocol, with the hypothesis that tandem administration of prostaglandin F2α (PG) and gonadotropin-releasing hormone (GnRH) during the presynchronization portion of the protocol would generate a convergent ovarian response among anestrous and estrous cycling females. Nulliparous, primiparous, and multiparous Angus and Angus-cross females were blocked based on parity and pre-treatment luteal status and, within a block, randomly assigned to one of three treatments. The females assigned to the 7 & 7 Synch treatment (n = 765) received an intravaginal progesterone-releasing insert (CIDR®) and an administration of PG on Day 0, GnRH on Day 7, and PG concurrent with CIDR removal on Day 14. Estrotect™ estrus detection aids were applied on Day 14 at the time of CIDR removal and PG administration. The females assigned to the 7 & 7 + G treatment (n = 769) received the same treatment schedule, with the modification that GnRH was administered in tandem with PG on Day 0. The females assigned to the 7 & 7 + G + P treatment (n = 786) received the same treatment schedule, with the modification that GnRH was administered in tandem with PG on both Days 0 and 7. Fixed-time artificial insemination (FTAI) was performed at 54 ± 2 h (nulliparous) or 66 ± 2 h (primiparous and multiparous) after CIDR removal. Transrectal ovarian ultrasonography was performed on Days 7 and 14 to characterize the largest follicle diameter (LFD) and the presence of corpora lutea (CL). Estrus prior to FTAI was characterized using estrus detection aids. Pregnancy status was determined via transrectal ultrasonography approximately 60–100 days after FTAI. The proportion of multiparous females with CL on Day 14 tended to be greater following treatment with 7 & 7 Synch or 7 & 7 + G (90% and 87%, respectively), as compared to females treated with 7 & 7 + G + P (82%; p = 0.09). A greater proportion of multiparous females expressed behavioral estrus prior to FTAI when treated with 7 & 7 + G + P (90%) as compared to multiparous females treated with 7 & 7 + G (79%; p < 0.002) or 7 & 7 Synch (78%; p = 0.0004); however, pregnancy rates resulting from FTAI did not differ based on treatment. In summary, tandem administration of GnRH and PG on Days 0 and 7 of the 7 & 7 Synch protocol effectively generated a convergent ovarian response among females with variable pretreatment luteal status but failed to enhance pregnancy rates to FTAI.
Open AccessTandem Administration of Prostaglandin F2α and Gonadotropin-Releasing Hormone in Beef Heifers and Cows as a Convergent Presynchronization Method in the 7 & 7 Synch Protocol
An experiment was designed to evaluate modifications to the 7 & 7 Synch protocol, with the hypothesis that tandem administration of prostaglandin F2α (PG) and gonadotropin-releasing hormone (GnRH) during the presynchronization portion of the protocol would generate a convergent ovarian response among anestrous and estrous cycling females. Nulliparous, primiparous, and multiparous Angus and Angus-cross females were blocked based on parity and pre-treatment luteal status and, within a block, randomly assigned to one of three treatments. The females assigned to the 7 & 7 Synch treatment (n = 765) received an intravaginal progesterone-releasing insert (CIDR®) and an administration of PG on Day 0, GnRH on Day 7, and PG concurrent with CIDR removal on Day 14. Estrotect™ estrus detection aids were applied on Day 14 at the time of CIDR removal and PG administration. The females assigned to the 7 & 7 + G treatment (n = 769) received the same treatment schedule, with the modification that GnRH was administered in tandem with PG on Day 0. The females assigned to the 7 & 7 + G + P treatment (n = 786) received the same treatment schedule, with the modification that GnRH was administered in tandem with PG on both Days 0 and 7. Fixed-time artificial insemination (FTAI) was performed at 54 ± 2 h (nulliparous) or 66 ± 2 h (primiparous and multiparous) after CIDR removal. Transrectal ovarian ultrasonography was performed on Days 7 and 14 to characterize the largest follicle diameter (LFD) and the presence of corpora lutea (CL). Estrus prior to FTAI was characterized using estrus detection aids. Pregnancy status was determined via transrectal ultrasonography approximately 60–100 days after FTAI. The proportion of multiparous females with CL on Day 14 tended to be greater following treatment with 7 & 7 Synch or 7 & 7 + G (90% and 87%, respectively), as compared to females treated with 7 & 7 + G + P (82%; p = 0.09). A greater proportion of multiparous females expressed behavioral estrus prior to FTAI when treated with 7 & 7 + G + P (90%) as compared to multiparous females treated with 7 & 7 + G (79%; p < 0.002) or 7 & 7 Synch (78%; p = 0.0004); however, pregnancy rates resulting from FTAI did not differ based on treatment. In summary, tandem administration of GnRH and PG on Days 0 and 7 of the 7 & 7 Synch protocol effectively generated a convergent ovarian response among females with variable pretreatment luteal status but failed to enhance pregnancy rates to FTAI.
- Open Access
- 21 March 2025
- Published by Springer Nature in Research Square
Enriching Electronic Health Records with Social Determinants of Health Data from Consumer Database: A Comparative Fit-for-Use Study
Although social determinants of health (SDH) significantly impact health outcomes, reliable data on SDH has not been widely accessible. Despite recent efforts to integrate more individual-level social determinants of health (I-SDH) data into electronic health records, the available sources of SDH that can be accessed at scale remain predominantly community-level, structured SDH (S-SDH). An alternative, though underutilized, strategy for collecting individual-level social determinants of health (I-SDH) is to link with third-party consumer databases that have accumulated socioeconomic status data over an extended period. In this pilot study, we aimed to systematically evaluate the quality and fitness-for-use (FFU) of a widely used consumer database for the prediction of 30-day unplanned hospital-wide, all-cause readmission (HW-ACR). We found that the inclusion of I-SDH not only provided significantly more predictive power over S-SDH but also allowed for the opportunity to explicitly uncover potential social risk factors that would otherwise remain hidden.
- 21 March 2025
- Published by Springer Nature in Research Square
Open AccessEnriching Electronic Health Records with Social Determinants of Health Data from Consumer Database: A Comparative Fit-for-Use Study
Although social determinants of health (SDH) significantly impact health outcomes, reliable data on SDH has not been widely accessible. Despite recent efforts to integrate more individual-level social determinants of health (I-SDH) data into electronic health records, the available sources of SDH that can be accessed at scale remain predominantly community-level, structured SDH (S-SDH). An alternative, though underutilized, strategy for collecting individual-level social determinants of health (I-SDH) is to link with third-party consumer databases that have accumulated socioeconomic status data over an extended period. In this pilot study, we aimed to systematically evaluate the quality and fitness-for-use (FFU) of a widely used consumer database for the prediction of 30-day unplanned hospital-wide, all-cause readmission (HW-ACR). We found that the inclusion of I-SDH not only provided significantly more predictive power over S-SDH but also allowed for the opportunity to explicitly uncover potential social risk factors that would otherwise remain hidden.
- 1 December 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 8 (8) , e2400196
Implementing Cancer Registry Data With the PCORnet Common Data Model: The Greater Plains Collaborative Experience
PURPOSE: Electronic health records (EHRs) comprise a rich source of real-world data for cancer studies, but they often lack critical structured data elements such as diagnosis date and disease stage. Fortunately, such concepts are available from hospital cancer registries. We describe experiences from integrating cancer registry data with EHR and billing data in an interoperable data model across a multisite clinical research network. METHODS: After sites implemented cancer registry data into a tumor table compatible with the PCORnet Common Data Model (CDM), distributed queries were performed to assess quality issues. After remediation of quality issues, another query produced descriptive frequencies of cancer types and demographic characteristics. This included linked BMI. We also report two current use cases of the new resource. RESULTS: Eleven sites implemented the tumor table, yielding a resource with data for 572,902 tumors. Institutional and technical barriers were surmounted to accomplish this. Variations in racial and ethnic distributions across the sites were observed; the percent of tumors among Black patients ranged from <1% to 15% across sites, and the percent of tumors among Hispanic patients ranged from 1% to 46% across sites. Current use cases include a pragmatic prospective cohort study of a rare cancer and a retrospective cohort study leveraging body size and chemotherapy dosing. CONCLUSION: Integrating cancer registry data with the PCORnet CDM across multiple institutions creates a powerful resource for cancer studies. It provides a wider array of structured, cancer-relevant concepts, and it allows investigators to examine variability in those concepts across many treatment environments. Having the CDM tumor table in place enhances the impact of the network's effectiveness for real-world cancer research.
- 1 December 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 8 (8) , e2400196
Implementing Cancer Registry Data With the PCORnet Common Data Model: The Greater Plains Collaborative Experience
PURPOSE: Electronic health records (EHRs) comprise a rich source of real-world data for cancer studies, but they often lack critical structured data elements such as diagnosis date and disease stage. Fortunately, such concepts are available from hospital cancer registries. We describe experiences from integrating cancer registry data with EHR and billing data in an interoperable data model across a multisite clinical research network. METHODS: After sites implemented cancer registry data into a tumor table compatible with the PCORnet Common Data Model (CDM), distributed queries were performed to assess quality issues. After remediation of quality issues, another query produced descriptive frequencies of cancer types and demographic characteristics. This included linked BMI. We also report two current use cases of the new resource. RESULTS: Eleven sites implemented the tumor table, yielding a resource with data for 572,902 tumors. Institutional and technical barriers were surmounted to accomplish this. Variations in racial and ethnic distributions across the sites were observed; the percent of tumors among Black patients ranged from <1% to 15% across sites, and the percent of tumors among Hispanic patients ranged from 1% to 46% across sites. Current use cases include a pragmatic prospective cohort study of a rare cancer and a retrospective cohort study leveraging body size and chemotherapy dosing. CONCLUSION: Integrating cancer registry data with the PCORnet CDM across multiple institutions creates a powerful resource for cancer studies. It provides a wider array of structured, cancer-relevant concepts, and it allows investigators to examine variability in those concepts across many treatment environments. Having the CDM tumor table in place enhances the impact of the network's effectiveness for real-world cancer research.
- 8 November 2023
- Published by Elsevier in Theriogenology
- Vol. 214, 334-341
Evaluation of later timepoints for fixed-time artificial insemination of beef heifers and cows when using sex-sorted semen
- 8 November 2023
- Published by Elsevier in Theriogenology
- Vol. 214, 334-341
Evaluation of later timepoints for fixed-time artificial insemination of beef heifers and cows when using sex-sorted semen
- Open Access
- 6 November 2023
- Published by Oxford University Press (OUP) in Journal of Animal Science
- Vol. 101 (Supplement) , 530-531
PSXIV-24 Inducing Luteolysis Before Atresia of the First Follicular Wave By Altering the Interval to Prostaglandin F2ɑ Administration After Long-Term Progestin Presynchronization
A series of experiments was designed to evaluate treatment schedules for control of the estrous cycle in which luteolysis is induced before atresia of the first follicular wave following a long-term progestin presynchronization treatment in beef heifers. The central hypothesis was that the proportion of heifers undergoing luteolysis and expressing estrus following PG administration would be affected by the duration of treatment with an intravaginal progesterone-releasing insert (CIDR; 1.38 g progesterone) and/or by the interval from CIDR removal to prostaglandin F2ɑ (PG; 500 µg cloprostenol) administration. In each experiment, heifers were blocked by reproductive tract score and body weight and assigned randomly within block to treatment. In Experiment 1, heifers (n = 91) were assigned to one of four treatments in a 2 x 2 factorial design: presynchronization via CIDR treatment for either 14 d or 18 d with administration of PG either 8 d or 9 d following CIDR removal. In Experiment 2, heifers (n = 63) were assigned to receive administration of PG either 9 d or 10 d following a 14 d CIDR presynchronization. In Experiment 3, heifers (n = 83) were assigned to receive administration of PG either 9 d or 16 d following a 14 d CIDR presynchronization. In Experiments 1 and 2, heifers were artificially insemination (AI) 8 to 12 h after expressing estrus, with timed AI performed 96 h after PG administration for heifers failing to express estrus. In Experiment 3, heifers expressing estrus by 66 h after PG administration were inseminated at that time and all remaining heifers were inseminated at 90 h. In Experiment 1, there was a tendency for a greater proportion of heifers to express estrus by 96 h after PG administration when PG administration occurred 9 d versus 8 d after CIDR removal (P = 0.07). Additionally, serum estradiol concentrations were greater at the time of PG administration when PG was administered 9 d versus 8 d after CIDR removal following an 18 d CIDR treatment (P = 0.006). In Experiment 2, pregnancy rate to AI (P/AI) was greater among heifers receiving PG administration 9 d versus 10 d after CIDR removal (P = 0.03). There was a tendency for largest follicle diameter measured at timed AI to be greater among non-estrous heifers receiving PG administration 10 d versus 9 d after CIDR removal (P < 0.08). In Experiment 3, there was a tendency for serum progesterone concentrations at the time of PG administration to be greater among heifers receiving PG administration 16 d versus 9 d after CIDR removal (P = 0.07). These results provide a preliminary evaluation of the feasibility of inducing luteolysis before atresia of the first follicular wave following long-term progestin presynchronization.
- 6 November 2023
- Published by Oxford University Press (OUP) in Journal of Animal Science
- Vol. 101 (Supplement) , 530-531
Open AccessPSXIV-24 Inducing Luteolysis Before Atresia of the First Follicular Wave By Altering the Interval to Prostaglandin F2ɑ Administration After Long-Term Progestin Presynchronization
A series of experiments was designed to evaluate treatment schedules for control of the estrous cycle in which luteolysis is induced before atresia of the first follicular wave following a long-term progestin presynchronization treatment in beef heifers. The central hypothesis was that the proportion of heifers undergoing luteolysis and expressing estrus following PG administration would be affected by the duration of treatment with an intravaginal progesterone-releasing insert (CIDR; 1.38 g progesterone) and/or by the interval from CIDR removal to prostaglandin F2ɑ (PG; 500 µg cloprostenol) administration. In each experiment, heifers were blocked by reproductive tract score and body weight and assigned randomly within block to treatment. In Experiment 1, heifers (n = 91) were assigned to one of four treatments in a 2 x 2 factorial design: presynchronization via CIDR treatment for either 14 d or 18 d with administration of PG either 8 d or 9 d following CIDR removal. In Experiment 2, heifers (n = 63) were assigned to receive administration of PG either 9 d or 10 d following a 14 d CIDR presynchronization. In Experiment 3, heifers (n = 83) were assigned to receive administration of PG either 9 d or 16 d following a 14 d CIDR presynchronization. In Experiments 1 and 2, heifers were artificially insemination (AI) 8 to 12 h after expressing estrus, with timed AI performed 96 h after PG administration for heifers failing to express estrus. In Experiment 3, heifers expressing estrus by 66 h after PG administration were inseminated at that time and all remaining heifers were inseminated at 90 h. In Experiment 1, there was a tendency for a greater proportion of heifers to express estrus by 96 h after PG administration when PG administration occurred 9 d versus 8 d after CIDR removal (P = 0.07). Additionally, serum estradiol concentrations were greater at the time of PG administration when PG was administered 9 d versus 8 d after CIDR removal following an 18 d CIDR treatment (P = 0.006). In Experiment 2, pregnancy rate to AI (P/AI) was greater among heifers receiving PG administration 9 d versus 10 d after CIDR removal (P = 0.03). There was a tendency for largest follicle diameter measured at timed AI to be greater among non-estrous heifers receiving PG administration 10 d versus 9 d after CIDR removal (P < 0.08). In Experiment 3, there was a tendency for serum progesterone concentrations at the time of PG administration to be greater among heifers receiving PG administration 16 d versus 9 d after CIDR removal (P = 0.07). These results provide a preliminary evaluation of the feasibility of inducing luteolysis before atresia of the first follicular wave following long-term progestin presynchronization.
- Open Access
Identification of large offspring syndrome during pregnancy through ultrasonography and maternal blood transcriptome analyses
The use of assisted reproductive technologies (ART) in cattle can result in large/abnormal offspring syndrome (LOS/AOS) which is characterized by macrosomia. LOS can cause dystocia and lead to the death of dam and calf. Currently, no test exists to identify LOS pregnancies. We hypothesized that fetal ultrasonography and/or maternal blood markers are useful to identify LOS. Bovine fetuses were generated by artificial insemination (control) or ART. Fetal ultrasonographies were taken on gestation day 55 (D55) and fetal collections performed on D56 or D105 (gestation in cattle ≈280 days). ART fetuses weighing ≥97 percentile of the control weight were considered LOS. Ultrasonography results show that the product of six D55 measurements can be used to identify extreme cases of LOS. To determine whether maternal blood can be used to identify LOS, leukocyte mRNA from 23 females was sequenced. Unsupervised hierarchical clustering grouped the transcriptomes of the two females carrying the two largest LOS fetuses. Comparison of the leukocyte transcriptomes of these two females to the transcriptome of all other females identified several misregulated transcripts on gestation D55 and D105 with LOC783838 and PCDH1 being misregulated at both time-points. Together our data suggest that LOS is identifiable during pregnancy in cattle.
Open AccessIdentification of large offspring syndrome during pregnancy through ultrasonography and maternal blood transcriptome analyses
The use of assisted reproductive technologies (ART) in cattle can result in large/abnormal offspring syndrome (LOS/AOS) which is characterized by macrosomia. LOS can cause dystocia and lead to the death of dam and calf. Currently, no test exists to identify LOS pregnancies. We hypothesized that fetal ultrasonography and/or maternal blood markers are useful to identify LOS. Bovine fetuses were generated by artificial insemination (control) or ART. Fetal ultrasonographies were taken on gestation day 55 (D55) and fetal collections performed on D56 or D105 (gestation in cattle ≈280 days). ART fetuses weighing ≥97 percentile of the control weight were considered LOS. Ultrasonography results show that the product of six D55 measurements can be used to identify extreme cases of LOS. To determine whether maternal blood can be used to identify LOS, leukocyte mRNA from 23 females was sequenced. Unsupervised hierarchical clustering grouped the transcriptomes of the two females carrying the two largest LOS fetuses. Comparison of the leukocyte transcriptomes of these two females to the transcriptome of all other females identified several misregulated transcripts on gestation D55 and D105 with LOC783838 and PCDH1 being misregulated at both time-points. Together our data suggest that LOS is identifiable during pregnancy in cattle.